Weight Management Research
Retatrutide
Purity 99%+ COA AvailableIn stock
Research Application
Triple agonist research peptide targeting GLP-1, GIP and glucagon receptors.
| Specifications | 5mg / 10mg / 20mg / 30mg |
| Purity | 99%+ |
| CAS No. | 2381089-83-2 |
| Research Application | Weight Management Research |
| Testing Method | HPLC, LC-MS |
| Packaging | Lyophilized powder in sealed glass vials; custom labels available |
| COA Availability | Batch-specific COA with every order |
| Shipping Support | Worldwide shipping with tracking, discreet export packaging |
For laboratory research use only. Not for human or veterinary use.
Testing Method
Each batch analyzed by RP-HPLC for purity and LC-MS for identity. Third-party testing available.
Packaging
2ml/3ml glass vials, flip-off caps, 10 vials per box. Custom labels and boxes supported.
Shipping Information
Dispatch in 1–3 business days. 5–10 days transit worldwide with tracking. Reship policy included.
Documentation
Certificate of Analysis
Every Retatrutide batch ships with its own COA including the HPLC chromatogram and MS spectrum. Request the latest batch report before ordering.
Request latest COACertificate of Analysis · Sample
Retatrutide
Batch NP-TZ-260915 · Mfg 2026-09-15
HPLC chromatogram · 220nm
| Test | Specification | Result |
|---|---|---|
| Appearance | White lyophilized powder | Conforms |
| Identity (LC-MS) | MW 4813.5 ± 1.0 | 4813.3 |
| Purity (HPLC) | ≥ 99.0% | 99.42% |
| Single impurity | ≤ 0.5% | 0.21% |
| Water (KF) | ≤ 8.0% | 4.6% |
| Peptide content | ≥ 80% | 86.7% |